Artificial Intelligence in daily routine management of malignant tumours
,
United Kingdom;
Yasushi Nagata,
Japan
This session will cover the current state-of-the-art of Artificial Intelligence (AI) for radiotherapy.
AI for target volume and organs at risk delineation will save our workload.
AI for dose calculation and adaptive radiotherapy will allow us more precise treatment.
Finally, future radiotherapy with AI will be discussed.
1440
Closing Symposium
Interdisciplinary